GemVax's highly promising Phase II Alzheimer's disease clinica...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SEOUL, South Korea, March 30, 2021 /PRNewswire-AsiaNet/ -- GemVax & KAEL Co., Ltd. (Korea: 082270) ("GemVax") has announced that a paper on GV1001, a novel Alzheimer's treatment based on telomerase modification, was published on March 26th in the SCI-grade international journal 'Alzheimer's Research & The...
Authors: LATEST ASIANET NEWS RELEASES